Previous 10 | Next 10 |
Asensus Surgical (NYSE:ASXC) has filed for a $150M mixed shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The company intends to use the proceeds for working capital and general corporate purposes, including R&D, commerciali...
Asensus Surgical Inc. (ASXC) Q4 2021 Results Conference Call February 28, 2022 4:30 PM ET Company Participants Anthony Fernando - CEO Shameze Rampertab - CFO Conference Call Participants Mark Klausner - Westwicke Swayampakula Ramakanth - H.C. Wainwright Ross Osborn - Cantor Fitzgerald Present...
Asensus Surgical press release (NYSE:ASXC): Q4 Non-GAAP EPS of -$0.07. Revenue of $2.48M (+123.4% Y/Y). Shares +2%. For further details see: Asensus Surgical Non-GAAP EPS of -$0.07, revenue of $2.48M
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the fourth quarter and full yea...
ACAD,ACHC,AGM,AMBA,AMRC,OTCPK:AOIFF,APLS,APPF,APTS,ARCT,ARDX,ASXC,ATRA,AVIR,AY,BANX,BIGC,BLFS,BLNK,BRMK,CAPL,CLDX,CO,CSR,CSTL,DAR,DDD,DNMR,DVAX,ENDP,EVA,FATE,FGEN,FRPT,FSK,GAIA,GDRX,GMRE,GOEV,GPOR,GRPN,HHC,HPQ,HRTX,ICAD,KD,LAZR,LCID,MBI,MDXG,MRTX,NKTR,NMFC,NVAX,NVEE,OCUL,OKE,ONTF,OTIC,PDCE,PG...
Asensus Surgical (NYSE:ASXC) is scheduled to announce Q4 earnings results on Monday, February 28th, after market close. The consensus EPS Estimate is -$0.07 (+22.2% Y/Y) and the consensus Revenue Estimate is $1.5M (+35.1% Y/Y). Over the last 2 years, ASXC has beaten EPS estimates 63% of the t...
Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 fourth quarter and fiscal year 2021 fina...
Setting a new standard with Performance-Guided Surgery New York, New York--(Newsfile Corp. - January 26, 2022) - -- PCG Digital-- Asensus Surgical, Inc. (NYSE American: ASXC) is leading the digital surgical market with a new concept known as Performance-Guided Surgery™. Asensus S...
In the surgical robotics industry, it's critically important that surgeons are able to trust robotic surgical systems. After all, surgeons' reputations and their patients' lives hang in the balance. In November, the digital surgery company Asensus Surgical (NYSEMKT: ASXC) report...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update. Fourth Quarter Highl...
News, Short Squeeze, Breakout and More Instantly...
Asensus Surgical Inc Com Company Name:
ASXC Stock Symbol:
NYSE Market:
Asensus Surgical Inc Com Website:
RESEARCH TRIANGLE PARK, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced that The Rocky Mountain Hospital for Children in Denver, Colorado, part of HCA Healthcare’s Health...
RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDAȁ...
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement ...